Korean epithelial ovarian cancer study (Ko-EVE): Protocols and interim report

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 8, 2012, Pages 3731-3740

  Ma, Seung Hyun ^a   Kim, Byoung Gie ^b   Choi, Ji Yeob ^a   Kim, Tae Joong ^b   Kim, Yong Man ^c   Kim, Jae Weon ^d   Kang, Sokbom ^e   Kang, Daehee ^a   Yoo, Keun Young ^a   Park, Sue K ^a  

^a Seoul National University   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c University of Ulsan College of Medicine   (South Korea)

^d Seoul National University Hospital   (South Korea)

^e National Cancer Center   (South Korea)

Author keywords

Case; Control study; Ko EVE study; Ovarian cancer; Protocol

Indexed keywords

EID: 84873674871     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.8.3731     Document Type: Article

References (73)

1. Ahn Y, Kwon E, Shim JE, et al (2007). Validation and reproducibility of food frequency questionnaire for Korean genome epidemiologic study. Eur J Clin Nutr, 61, 1435-41.
2. Aktas D, Guney I, Alikasifoglu M, et al (2002). CYP1A1 gene polymorphism and risk of epithelial ovarian neoplasm. Gynecol Oncol, 86, 124-8.
3. Bertone E R, Rosner B A, Hunter D J, Stampfer M J, Speizer F E, et al (2002). Dietary fat intake and ovarian cancer in a cohort of US women. Am J Epidemiol, 156, 22-31.
4. Chang Y M, Tai CF, Yang S C, et al (2003). A cohort mortality study of workers exposed to chlorinated organic solvents in Taiwan. Ann Epidemiol, 13, 652-660.
5. Chen Y, Wu PC, Lang JH, et al (1992). Risk factors for epithelial ovarian cancer in Beijing, China. Int J Epidemiol, 21, 23-29.
6. Chiu H F, Chang CC, Yang C Y (2004). Magnesium and calcium in drinking water and risk of death from ovarian cancer. Magnesium Res, 17, 28-34.
7. Cho LY, Kim CS, Li L, Yang J J, Park B, et al (2009). Validation of self-reported cancer incidence at follow-up in a prospective cohort study. Ann Epidemiol, 19, 644-6.
8. Ferlay J, Shin H R, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-2917.
9. Fujita M, Tase T, Kakugawa Y, et al (2008). Smoking, earlier menarche and low parity as independent risk factors for gynecologic cancers in Japanese: a case-control study. Tohoku J Exp Med, 216, 297-307.
10. Han S, Lee K M, Choi J Y, Park S K, Lee J Y, et al (2008). CASP8 polymorphisms, estrogen and progesterone receptor status, and breast cancer risk. Breast Cancer Res Treat, 110, 387-93.
11. Hirose K, Tajima K, Hamajima N, Kuroishi T, Kuzuya K, et al (1999). Comparative case referent study of risk factors among hormone-related female cancers in Japan. Cancer Science, 90, 255-61.
12. Inoue M, Iwasaki M, Otani T, Sasazuki S, Noda M, et al (2006). Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Internal Med, 166, 1871.
13. Jeong N H, Song E S, Lee J M, Lee K B, Kim M K, et al (2009). Plasma carotenoids, retinol and tocopherol levels and the risk of ovarian cancer. Acta Obstet Gynecol Scand, 88, 457-62.
14. Jordan S, Green A and Webb P (2006). Benign epithelial ovarian tumours-cancer precursors or markers for ovarian cancer risk? Cancer Causes Control, 17, 623-632.
15. Kang S, Duan L H, Li Y, et al (2004). Relation between microsomal epoxide hydrolase polymorphism and susceptibility to ovarian epithelial cancer. Zhonghua Fu Chan Ke Za Zhi, 39, 556-7 (in Chinese).
16. Kato I, Tominaga S and Terao C (1989). Alcohol consumption and cancers of hormone-related organs in females. Jpn J Clin Oncol, 19, 202-207.
17. Kim MK, Kim K, Kim SM, et al (2009). A hospital-based case-control study of identifying ovarian cancer using symptom index. J Gynecol Oncol, 20, 238-242.
18. Kim YM, Whang DH, Park J, et al (2011). Evaluation of the accuracy of serum human epididymis protein 4 in combination with CA125 for detecting ovarian cancer: a prospective case-control study in a Korean population. Clin Chem Lab Med, 49, 527-534.
19. Kobayashi H, Sumimoto K, Moniwa N, et al (2007). Risk of developing ovarian cancer among women with ovarian endometrioma: a cohort study in Shizuoka, Japan. Int J Gynecol Cancer, 17, 37-43.
20. Kolahdooz F, van der Pols JC, Bain CJ, et al (2010). Meat, fish, and ovarian cancer risk: Results from 2 Australian case-control studies, a systematic review, and meta-analysis. Am J Clin Nutr, 91, 1752-63.
21. Lalwani N, Prasad S R, Vikram R, et al (2011). Histologic, molecular, and cytogenetic features of ovarian cancers: implications for diagnosis and treatment. Radiographics, 31, 625-46.
22. Larsson SC, Wolk A (2005). No association of meat, fish, and egg consumption with ovarian cancer risk. Cancer Epidemiol Biomarkers Prev, 14, 1024-5.
23. Lee JY, Park A K, Lee KM, et al (2009). Candidate gene approach evaluates association between innate immunity genes and breast cancer risk in Korean women. Carcinogenesis, 30, 1528-31.
24. Lee KM, Park SK, Hamajima N, et al (2005). Genetic polymorphisms of TGF-beta1 & TNF-beta and breast cancer risk. Breast Cancer Res Treat, 90, 149-55.
25. Li Y, Jin X, Kang S, et al (2006). Polymorphisms in the promoter regions of the matrix metalloproteinases-1, -3, -7, and -9 and the risk of epithelial ovarian cancer in China. Gynecol Oncol, 101, 92-6.
26. Li Y, Liang J, Kang S, et al (2008). E-cadherin gene polymorphisms and haplotype associated with the occurrence of epithelial ovarian cancer in Chinese. Gynecol Oncol, 108, 409-14.
27. Li Y, Wang Y, Kang S, et al (2010). Association of vascular endothelial growth factor gene polymorphisms with susceptibility to epithelial ovarian cancer. Int J Gynecol Cancer, 20, 717-23.
28. Lin HW, Tu YY, Lin SY, et al (2011). Risk of ovarian cancer in women with pelvic inflammatory disease: a population-based study. Lancet Oncol, 12, 900-4.
29. Liu FYC (2010). Association between CYP1A1 Ile/Val polymorphisms and ovarian cancer risk. J Hebei North Univ (Med Ed), 27, 29-30.
30. Lynch H T, Casey M J, Snyder C L, et al (2009). Hereditary ovarian cancer: Molecular genetics, pathology, management, and heterogeneity. Molecular Oncology, 3, 97.
31. Ma X, Zhang J, Liu S, et al (2011). Polymorphisms in the CASP8 gene and the risk of epithelial ovarian cancer. Gynecol Oncol, 122, 554-559.
32. Ministry of Health & Welfare KCfDCaP (2009). Korea National Health & Nutrition Examination Survey., from Available from: http://knhanes.cdc.go.kr/.
33. Ministry of Health and Welfare (2012). National Cancer Information Center from Available from: http://www.cancer.go.kr/cms/statics/incidence/index.html#4..
34. Mori M, Harabuchi I, Miyake H, et al (1988). Reproductive, genetic, and dietary risk factors for ovarian cancer. Am J Epidemiol, 128, 771-777.
35. Mori M, Kiyosawa H, Miyake H (1984). Case-control study of ovarian cancer in Japan. Cancer, 53, 2746-52.
36. Mori M, Nishida T, Sugiyama T, et al (1998). Anthropometric and other risk factors for ovarian cancer in a case-control study. Jpn J Cancer Res, 89, 246-53.
37. Nandakumar A, Anantha N, Dhar M, Ahuja V, Kumar R, et al (1995). A case control investigation on cancer of the ovary in Bangalore, India. Int J Cancer, 63, 361-5.
38. Niwa Y, Wakai K, Suzuki S, et al (2005). Cigarette smoking and the risk of ovarian cancer in the Japanese population: findings from the Japanese Collaborate Cohort study. J Obstet Gynaecol Res, 31, 144-51.
39. Niwa Y, Yatsuya H, Tamakoshi K, et al (2005). Relationship between body mass index and the risk of ovarian cancer in the Japanese population: findings from the Japanese Collaborate Cohort (JACC) study. J Obstet Gynaecol Res, 31, 452-8.
40. Office KNS (2009). The pilot result of birth statistics in 2009 from Available from: http://kostat.go.kr/.
41. Pan SY, Ugnat AM, Mao Y, et al (2004). A case-control study of diet and the risk of ovarian cancer. Cancer Epidemiol Biomarkers Prev, 13, 1521-1527.
42. Park B, Kim TJ, Ma SH, et al (2010). Epidemiological characteristics of ovarian cancer in Korea. J Gynecol Oncol, 21, 241.
43. Park J, Hilmers DC, Mendoza JA, et al (2010). Prevalence of metabolic syndrome and obesity in adolescents aged 12 to 19 years: comparison between the United States and Korea. J Korean Med Sci, 25, 75-82.
44. Park SK, Yoo KY, Lee SJ, et al (2000). Alcohol consumption, glutathione S-transferase M1 and T1 genetic polymorphisms and breast cancer risk. Pharmacogenetics, 10, 301-309.
45. Park YS, Lee DH, Choi JM, et al (2004). Trend of obesity in school age children in Seoul over the past 23 years. Korean J Pediatrics, 47, 247-57.
46. Qie M, Zhang Y, Wu J (2002). Study on the relationship between cervical cancer and p53 codon 72 polymorphism. J West China Univ Med Sci, 33, 274 (in Chinese).
47. Sakauchi F, Khan M M, Mori M, et al (2007). Dietary habits and risk of ovarian cancer death in a large-scale cohort study (JACC study) in Japan. Nutr Cancer, 57, 138-145.
48. Schulz M, Nothlings U, Allen N, et al (2007). No association of consumption of animal foods with risk of ovarian cancer. Cancer Epidemiol Biomarkers Prev, 16, 852-5.
49. Shu XO, Gao YT, Yuan JM, et al (1989). Dietary factors and epithelial ovarian cancer. Br J Cancer, 59, 92-96.
50. Sokal D C, Vach T H, Nanda K, et al (2010). Quinacrine sterilization and gynecologic cancers: A case-control study in northern Vietnam. Epidemiology, 21, 164.
51. Sugawara T, Nomura E, Sagawa T, et al (2003). CYP1A1 polymorphism and risk of gynecological malignancy in Japan. Int J Gynecol Cancer, 13, 785-790.
52. Ueda M, Terai Y, Kanda K, et al (2006). Germline polymorphism of p53 codon 72 in gynecological cancer. Gynecol Oncol, 100, 173-8.
53. Wernli KJ, Ray RM, Gao DL, et al (2008). Occupational exposures and ovarian cancer in textile workers. Epidemiology, 19, 244-50.
54. Woong-Shick A, Sung-Pil P, Su-Mi B, et al (2005). Identification of hemoglobin-alpha and -beta subunits as potential serum biomarkers for the diagnosis and prognosis of ovarian cancer. Cancer Sci, 96, 197-201.
55. Xie X, Ye D, Chen H, et al (2004). Interleukin-7 and suppression of local peritoneal immunity in ovarian carcinoma. Int J Gynecol Obstets, 85, 151-8.
56. Yang C, Chan K, Ngan H, et al (2006). Single nucleotide polymorphisms of follicle-stimulating hormone receptor are associated with ovarian cancer susceptibility. Carcinogenesis, 27, 1502.
57. Yang XY, Yu H, Xi MR, et al (2009). Association of the ARLTS1 variants with familial ovarian cancer risk in China. Int J Gynecol Cancer, 19, 585-90.
58. Yen M L, Yen B L, Bai C H, et al (2003). Risk factors for ovarian cancer in Taiwan: a case-control study in a low-incidence population. Gynecol Oncol, 89, 318-324.
59. Yun T K, Choi S Y (1995). Preventive effect of ginseng intake against various human cancers: a case-control study on 1987 pairs. Cancer Epidemiology Biomarkers & Prevention, 4, 401-8.
60. Zhang H, Zhang S, Cui J, et al (2008). Expression and promoter methylation status of mismatch repair gene hMLH1 and hMSH2 in epithelial ovarian cancer. Aust NZ J Obstets Gynaecol, 48, 505-9.
61. Zhang M, Binns CW, Lee AH (2002a). Tea consumption and ovarian cancer risk: a case-control study in China. Cancer Epidemiol Biomarkers Prev, 11, 713-8.
62. Zhang M, Holman CD, Binns C W (2007). Intake of specific carotenoids and the risk of epithelial ovarian cancer. Br J Nutr, 98, 187-93.
63. Zhang M, Lee A H, Binns CW (2003). Physical activity and epithelial ovarian cancer risk: a case-control study in China. Int J Cancer, 105, 838-43.
64. Zhang M, Lee AH, Binns CW (2004a). Reproductive and dietary risk factors for epithelial ovarian cancer in China. Gynecol Oncol, 92, 320-6.
65. Zhang M, Xie X, Holman CD (2005). Body weight and body mass index and ovarian cancer risk: a case-control study in China. Gynecol Oncol, 98, 228-34.
66. Zhang M, Xie X, Lee AH, Binns CW (2004b). Prolongedlactation reduces ovarian cancer risk in Chinese women. Eur J Cancer Prev, 13, 499-502.
67. Zhang M, Xie X, Lee A H, et al (2004c). Sedentary behaviours and epithelial ovarian cancer risk. Cancer Causes and Control, 15, 83-89.
68. Zhang M, Xie X, Lee A H, et al (2004d). Soy and isoflavone intake are associated with reduced risk of ovarian cancer in southeast china. Nutr Cancer, 49, 125-130.
69. Zhang M, Yang Z Y, Binns C, et al (2002b). Diet and ovarian cancer risk: a case-control study in China. Br J Cancer, 86, 712-717.
70. Zhang Z, Zhou B, Zhang J, et al (2010). Association of interleukin-23 receptor gene polymorphisms with risk of ovarian cancer. Cancer Genet Cytogenet, 196, 146-152.
71. Zhen H, Yang S, Wu H, et al (2010). LyGDI is a promising biomarker for ovarian cancer. Int J Gynecol Cancer, 20, 316-322.
72. Zou L, He X, Zhang JW (2010). The efficacy of YKL-40 and CA125 as biomarkers for epithelial ovarian cancer. Braz J Med Biol Res, 43, 1232-1238.
73. Zy Z, Yq M, Xm F, et al (2010). Relationship between CYP1A1 gene polymorphism and susceptibility of ovarian cancer. Chin J Cancer Prev Treat, 17, 1325-7.